Bronchodilator Responsiveness Does Not Help Determine Anti-IL-5 Targeted Biologic Success in Patients With Severe Asthma
J Allergy Clin Immunol Pract
.
2022 Dec;10(12):3184-3185.
doi: 10.1016/j.jaip.2022.09.023.
Authors
Wei Zhao
1
,
Mary Beth Hogan
2
Affiliations
1
Division of Allergy and Immunology, Department of Pediatrics, Virginia Commonwealth University, Richmond, Va. Electronic address:
[email protected]
.
2
Section of Allergy/Immunology, Department of Pediatrics, Marshall University, Huntington, WVa.
PMID:
36496212
DOI:
10.1016/j.jaip.2022.09.023
No abstract available
Publication types
Editorial
Comment
MeSH terms
Albuterol / therapeutic use
Asthma* / drug therapy
Bronchodilator Agents* / therapeutic use
Humans
Substances
Bronchodilator Agents
Albuterol